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Abstract  
Computer-aided design for synthetic biology promises to accelerate the rational and robust 
engineering of biological systems; it requires both detailed and quantitative mathematical and 
experimental models of the processes to (re)design, and software and tools for genetic 
engineering and DNA assembly. Ultimately, the increased precision in the design phase will 
have a dramatic impact on the production of designer cells and organisms with bespoke 
functions and increased modularity. Computer-aided design strategies require quantitative 
representations of cells, able to capture multiscale processes and link genotypes to phenotypes. 
Here, we present a perspective on how whole-cell, multiscale models could transform design-
build-test-learn cycles in synthetic biology. We show how these models could significantly aid 
in the design and learn phases while reducing experimental testing by presenting case studies 
spanning from genome minimization to cell-free systems, and we discuss several challenges 
for the realization of our vision. The possibility to describe and build in silico whole-cells offers 
an opportunity to develop increasingly automatized, precise and accessible computer-aided 
design tools and strategies throughout novel interdisciplinary collaborations. 
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       1. Introduction 
Whole-cell models (WCMs) are state-of-the-art Systems Biology formalisms: they aim at 
representing and integrating all cellular functions within a unique computational framework, 
ultimately enabling a holistic and quantitative understanding of cell biology (1, 2). Quantitative 
and high-throughput in silico experiments generated from WCMs promise to significantly 
shorten the distance between hypothesis/design formulation and testing (3). 
 While simplified models for specific cellular functions were first developed over 30 
years ago (e.g. formalisms for gene expression regulation (4), signaling (5) and metabolic (6) 
pathways, cell growth (7) and the cell cycle (8-10)), the first WCM, namely the E-Cell model, 
was only derived in the 1990s for Mycoplasma genitalium, the smallest living organisms with 
a 580 kb genome, following publication of the organism genome sequence (11). The so-called 
virtual self-surviving cell (SSC) partially stochastic model includes only a subset of protein-
coding genes (105) and enables dynamic simulations which encompass various subcellular 
processes, including enzymatic reactions, complex formation and substance translocation. In 
parallel, the first genome-scale metabolic models (GSMMs) were developed by Palsson’s 
group (12) using flux balance analysis (FBA) in the 1990s.  
 More recently, hundreds of GSMMs have been reconstructed for different organisms, 
with an increasing number of represented genes (13-15). GSMMs have been complemented 
with a mathematical description of other processes, such as transcription, translation and 
signaling (16, 17). Less than a decade ago the first hybrid dynamic model, representing all 
genes and molecular functions known for an organism, was proposed by Covert’s group (18). 
In this pioneering work, Karr and colleagues integrated 28 sub-models within a unique 
MATLAB WCM to represent one cell cycle of M. genitalium; each sub-model is represented 
with a distinct formalism, including ordinary differential equations (ODEs), flux balance 
analysis (FBA), stochastic simulations and Boolean rules. 
 Substantial research and effort are still needed to improve WCMs’ descriptive power 
and to increase the complexity of organisms they can represent. A complete WCM should 
ideally integrate multiscale interactions at the cellular level (18, 19) while accounting for the 
overall cellular structure (20), the dynamic structure of molecular interactions (21-23) and the 
spatial compartment of the subcellular components (24-26). Ensuring an accurate 
representation of all the mentioned processes is highly challenging, especially when aiming to 
model increasingly complex organisms (27-29). We refer the reader to recent efforts which 
provide an overview of the state-of-the-art in the development of WCMs (30, 31).  
 Here, we focus on the enormous potential we believe WCMs have for design-build-test 
cycles integrating synthetic with systems biology (Figure 1). While the discussed applications 
are diverse, they share a high degree of complexity which would imply extensive trial and error 
experimental cycles in the absence of robust computational design algorithms based on 
predictive models. We conclude by considering relevant challenges that interdisciplinary 
communities should address to fully realize our vision, discussing future directions for the 
integration of WCM development through synthetic and systems biology applications. 
 
2. Whole-cell design strategies in synthetic biology 
2.1 Model granularity of gene network (re)design 
Mathematical models can be instrumental to (re)design network circuits that recapitulate 
definite biological functions. Knowledge of regulatory mechanisms in biological pathways has 
been gained by considering living systems as a composition of functional modules, which are 
investigated through minimal computer models. Examples include controllable oscillators (32-
35), circadian clocks (36, 37), signaling networks (38), the metabolism (39, 40) and 
transcriptional regulation (41). The granularity of biochemical details uncovered about a 
definite regulatory network may differ between minimal and detailed computer models. 
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However, one may expect that if the core design of a minimal and a detailed model is similar, 
their general properties will match. 
Understanding of a living organism at a system’s level may be reached through 
decomposing a system into functional modules, or modular circuits that perform a definite task 
(42-44). The capability to sustain viability through autonomously generated offspring is 
essential for organismal functions and, therefore, is a feature WCMs shall account through 
modeling cell division, which is intimately integrated with various layers of cellular regulation 
(metabolism, signaling, gene regulation, transcription, etc.). A number of minimal models have 
been developed for the eukaryotic cell cycle by Barberis’s, Tyson’s and Novák’s groups (45-
50). 
Currently, the majority of multiscale models (not WCMs) lack components able to 
bridge cellular networks/function (cell cycle, metabolism, signaling, gene regulation, etc.). 
Identification of hubs, i.e. elements with high connectivity in the cellular environment that 
integrate cellular networks, is a critical feature of WCMs. Transcription factors have recently 
been identified as hubs that integrate multiscale networks, potentially connecting the cell cycle 
to metabolism (51), and can be among the parts of a system that influence its state as a whole. 
Multiscale frameworks coupling a variable granularity of these networks are being developed, 
by identifying the relevant regulations occurring among common network nodes and through 
the use of different mathematical formalisms (52). These and other strategies are developed to 
progressively integrate networks of other cellular functional modules (53). Together with the 
identification of network designs underlying cell’s autonomous oscillations, these strategies 
can rationalize the proper timing of offspring generation accounted by WCMs. 
Designing synthetic gene networks by integrating them within WCM formalisms (as in 
(33)) could be critical to investigate how gene expression correlates with codon usage, explore 
possible cell burden effects (54), and predict modularity of synthetic gene networks and tools 
to modulate gene expression across different chassis (55-57). 
 
2.2 Design and engineering of reduced genomes  
Minimal genomes can be defined as reduced genomes containing only the genetic material 
which is essential for a cell to reproduce (58). Studying and engineering minimal genomes can 
be instrumental both to understand the most essential tasks a cell must perform to sustain life, 
and to obtain optimal chassis for synthetic biology applications, with reduced cell burden and 
superior robustness (59-63). Genome-scale computational models of cells can be instrumental 
to fully understand the dynamic and context-dependent nature of gene essentiality (64), and to 
rationally design minimized genomes in silico. Computer-aided minimal genome engineering 
could significantly reduce the time and cost of approaches used so far to produce reduced 
genomes, which can otherwise be generated by extensive experimental iterations (60, 65-70). 
 To the best of our knowledge, two top-down genome reduction approaches have been 
proposed so far based on computational genome-scale models. The MinGenome algorithm 
applies a mixed-integer linear programming (MILP) algorithm to a GSMM of E. coli, using 
information pertaining to essential genes and synthetic lethal pairs within the optimization (71). 
In contrast, Minesweeper and GAMA are top-down genome minimization algorithms based on 
the M. genitalium WCM. They exploit a divide-and-conquer approach and a genetic algorithm, 
respectively, to iteratively simulate reduced genomes (72); their in silico predictions have not 
been tested in the laboratory yet. 
 Applying GSMM-based genome reduction algorithms such as MinGenome or 
analogous metaheuristic equivalents which could be easily adapted for this aim (e.g. (73-75) 
is, at the current stage, more broadly applicable across organisms given the large availability 
of these formalisms. Still, as more WCMs become available, we expect WCM-based genome 
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reduction algorithms to provide superior predictions of cellular processes and genetic 
interactions, thanks to their richness of multiscale cellular process representation. 
 
     2.3 Design and prototyping of cell-free systems 
Cell-free transcription/translation systems, based on crude cellular extracts, are a valuable 
platform to address fundamental biological questions in a controllable and reproducible way. 
In recent years, the decrease of costs associated with this technology and significant 
improvements in synthesis yield capabilities (76) have made cell-free systems increasingly 
popular in synthetic biology for the prototyping and testing of engineered biological parts (13-
15, 70) and networks (77-79). As the possible applications of cell-free systems grow (see (80) 
for a recent review where a spectrum of cell-free probing of cellular functions and of 
applications are discussed in detail), mathematical models are developed to quantitatively 
formalize how biological processes perform within cell-free platforms (81).  
 So far, deterministic models (ordinary differential equations-, or constraint-based) have 
been proposed to describe specific processes within cell-free platforms such as transcription 
and translation (78, 82, 83), resource competition (84-87) and metabolism (88). The integration 
of mathematical formalisms across scales for cell-free platforms, building towards WCMs, 
could be highly beneficial to both facilitate de novo design of circuits, and to quantitatively 
compare in vitro cell-free products with their in vivo counterparts. 
 
2.4 Whole-cell biosensor design and testing 
Biosensors are analytical devices which can convert a biochemical reaction into a measurable 
signal. The recognition unit in a biosensor can be composed of whole cells, nucleic acids, 
enzymes, proteins, antibodies or combinations thereof. Synthetic biology has significantly 
accelerated biosensor development; new generation whole-cell biosensors (i.e. sensors 
implemented throughout living cells) have been engineered, for example, to detect arsenic (89) 
and other analytes (including pollutants and antibiotics (90)), for microbial detection in 
industrial settings (91) and for in vivo diagnostic applications (e.g. detection of environmental 
signals in the gut (92) and diagnosis of liver metastases (93); see (94) for an overview of 
translation of promising technologies into diagnostic tools).  
 The application of WCMs to the design, prototyping and testing of whole-cell 
biosensors could suggest rational approaches to tune their sensitivity, stability and dynamic 
range while facilitating the choice of the ideal chassis and, if needed, guide its re-engineering 
to optimize biosensor performance (95). If WCMs become available for different chassis and 
entire organisms, they could also support the design of optimized targeted delivery of 
genetically encoded biosensors. 
 
2.5 Industrial implications of whole-cell models  
Although the intellectual merit of pursuing a computer-aided whole-cell design approach is 
unquestioned, it is clear that the success of this endeavor will ultimately be judged by its impact 
on industry. The increasing drive towards ‘green’ chemistry approaches, allied to increases in 
gene synthesis speed and capability and associated cost reductions, are making biosynthesis an 
increasingly appealing route for the manufacture of high-value chemicals (96). This includes a 
plethora of opportunities across the pharmaceutical, agrochemical, commodity chemical, and 
materials sectors, amongst others.  
 A major challenge, however, remains the development of robust, scalable microbial 
chassis, whose metabolic processes can be predictably tuned for a desired outcome (97). 
Currently, chassis choice is largely restricted to a subset of genetically tractable 
microorganisms, whose physiology and performance during fermentation are well understood, 
and for whom effective molecular genetic tools required for their manipulation exist. Chassis 
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optimization to date has relied exclusively on incremental, stepwise improvements in desired 
host strain characteristics, including growth rate, feedstock utilization and product yield (98). 
For these reasons, the process of chassis optimization remains prohibitively slow and 
expensive, accounting in part for the paucity of high-value small molecules that are currently 
manufactured using synthetic biology processes. Targeted manipulations often lead to 
unanticipated off-target effects, linked to the co-dependency of metabolic processes, which 
generally function in concert within interdependent cellular networks (99): perturbations may 
compromise rather than enhance desirable characteristics, leading to undesired outcomes. 
Clearly, robust, predictable WCMs represent an attractive solution to the problem of chassis 
optimization, affording a catch-all tool that can be used to unpick dependencies and ensure that 
performance criteria can be met. Besides, the complexities associated with population 
heterogeneity during chassis fermentation must be resolved (100). For fermentation-based 
industrial processes to be tractable, product yields must be sufficiently high to make 
biosynthesis financially viable. The emergence of ‘cheaters’ or slow-growers within microbial 
populations must be addressed. This will undoubtably be best achieved through tunable 
regulatory processes that operate throughout populations. The introduction of such 
characteristics is a major challenge to conventional chassis design approaches. However, this 
could be much more easily implemented and tested by employing WCM driven approaches.  
 Critical to the success of a computer-aided whole-cell design approach is the quality of 
the employed model (101). Microbial systems with small genomes represent a compelling entry 
point for study, with model development possibly being facilitated by ongoing studies focused 
on establishing the core constituents of a functional genome. These studies are being 
predominantly driven by genome minimization experiments, which in turn can be used to 
further refine model performance. Importantly, fundamental gaps remain in our understanding 
of microbial metabolic processes, and this will unquestionably hinder progress (102). However, 
the capacity of WCMs to predict previously unidentified metabolic dependencies should be 
viewed as an acid test of model validity. Indeed, GSMMs often fail due to their inability to 
account for interdependencies, a feature which has led to skepticism within industrial circles, 
questioning the value of such models. Whole-cell approaches offer a mechanism to circumvent 
this issue and could increase reliability and promote confidence in the adoption of WCMs. This 
is of particular significance when developing chassis for ‘non-natural’ products whose 
chemistries sit outside those of metabolites found in nature (98). Expanding the metabolic 
capacity of chassis organisms to deliver such novel products risks introducing additional 
complexities, including excessive depletion of core metabolite pools or the generation of toxic 
products or intermediates. Design approaches driven by WCMs are uniquely placed to identify 
such issues and provide a route to their circumvention.  
 The capacity to design-in explicit control over cellular behavior is also critical for 
industrial adoption of model-derived chassis. It can be argued that the ability to regulate cellular 
processes is as important as defining the processes themselves. Tunable regulatory systems 
must afford a degree of both intrinsic and extrinsic control. Synthetic biology-based approaches 
for the construction of genetic circuitry are now placing us on a path to broad-reaching cellular 
regulation, though issues still exist. These systems are often insufficiently orthogonal, with 
bespoke designs required for different chassis due to variations in core metabolic process (39). 
Again, whole-cell design approaches offer a solution to this issue, as such systems can be 
predefined and tested for functionality in silico prior to undertaking costly lab experimentation. 
 
3. What’s next? Going beyond the prototype 
In recent years, advances in genomic measurement technologies for data generation, the 
establishment of data repositories, and the development of WCM simulation platforms have 
significantly facilitated the derivation of WCMs (see (30) for a review). Nevertheless, the 
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implementation of WCM-based design-build-test cycles for genome-scale engineering requires 
further challenges to be addressed (103).  
 If a model has to be used for the design and prototyping of an engineered living system, 
the model needs to be reliable. Even for a simple organism, the number of kinetic parameters 
surges as the complexity and the level of detail of a mathematical model increase; constraining 
parameters thus becomes harder and requires extensive experimental data. To set the 1,462 
quantitative parameters of the M. genitalium WCM, values from other species were 
incorporated due to a lack of organism-specific data (104); a combination of parameter values 
reported from previous experiments and numerical optimization on a reduced model was 
performed. While, ideally, we would like to measure all kinetic parameters directly from 
experiments, we still lack techniques to measure each state in individual cells over time, and 
across all possible environmental conditions. Mathematical models can be used to produce 
predictions of missing data, however they often abstract physical processes using simplifying 
assumptions which might hold in specific conditions only (105). A combination of direct 
experimental estimation and parameter inference might be needed for genome-scale 
formalisms and WCMs, for example using scalable inference techniques to parameterize sub-
models. 
 Sensitivity analysis, usually performed by perturbing parameters to understand how 
uncertainties affect the model outputs (106), can become extremely computationally expensive 
when applied to genome-scale models. Alternatively, statistical approaches such as those based 
on Bayesian methods (107) or on the Fisher information matrix (108) could be carefully carried 
out at least at the sub-model level, and possibly scaled up to WCMs. The Reverse Engineering 
Assessments and Methods (DREAM8) parameter estimation challenge (109) was organized to 
develop new parameter estimation techniques specific for WCMs. It suggested possible 
interesting avenues for WCM parameterization (i.e. model reduction and a combination of 
differential evolution and random forests), and highlighted that the availability of 
comprehensive data-set is critical to ensure the model is practically identifiable (110).  
 It is also important to consider the structural uncertainties in the model, which depend 
on model assumptions. While, for certain sets of models (e.g. small ordinary differential 
equation systems for signaling pathways), likelihood- and Bayesian-based approaches have 
been proposed for model selection (111) (112) and Semidefinite Programming for model 
invalidation (113), no suitable techniques for WCM selection have been proposed to date. 
 We foresee that automation will play a fundamental role in the derivation of WCMs for 
eukaryotic organisms and in their application to design complex processes. Ideally, we would 
like to introduce automation at different stages, such as data extraction from the literature, 
model derivation, and model/data integration both within the model fitting and validation steps, 
and when comparing in vitro design prediction with in vivo tests (103). This, in turn, will 
require the adoption of standards for both data and model repositories. 
 Researchers have started to collect data needed for WCM development into public 
repositories (e.g. (114-118)); still, data needed to derive and fit WCMs are dispersed across 
many repositories and publications and often not annotated or normalized, ultimately requiring 
a massive manual effort. Federated archives of repositories, such as the PDB-Dev system to 
deposit Integrative/Hybrid models and corresponding data (119), might be well placed to 
archive and disseminate both data and models, while enabling different researchers to attempt 
alternative modelling/parameterization approaches. Covert’s group developed the 
WholeCellKB database (120) to organize the quantitative measurements (over 1,400) from 
which the M. genitalium WCM was derived; it would be ideal to enable automatic access and 
querying in such databases.  
 To enhance WCM reproducibility, new standards and simulations software are also 
needed (121). Researchers should invest efforts to use standard formats such as the Systems 
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Biology Markup Language (SBML) (122) and the Systems Biology Graphical Notation 
(SBGN) (123). At present, various aspects of the M. genitalium WCM cannot be represented 
by SBML, mainly due to the multi-algorithmic nature of the model itself (124). Further 
development of standard modelling formats is needed to enable reproducible WCM 
simulations, e.g. by including in the SMBL Hierarchical Model Composition package 
ontologies which could represent the algorithm needed for specific sub-models (125). In the 
context of synthetic biology applications, we believe it would be appropriate and beneficial to 
report and deposit data related to various iterations of WCM-generated in silico predictions, in 
vivo testing and possible model/design refinement; this would establish the predictive power 
of WCMs and illuminate steps to make design-build-test-learn cycles more effective. 
 To facilitate the adoption of WCMs for synthetic biology applications, high-
performance parallelized computer clusters are required to coordinate and run the models with 
lengthy runtimes and large corresponding databases across computer clusters, to parameterize 
and validate the models, and then to integrate them in design cycles in combination with 
optimization algorithms (104) (126). 
 The implementation of standardized tools to share data and simulate WCMs would, in 
turn, facilitate model validation. This should involve the definition of proper metrics and formal 
model verification techniques such as those developed for SBML-encoded models (127).  
 
4. (Re)thinking system approaches: a collaborative effort 
In addressing the aforementioned challenges, we believe there is a tremendous opportunity to 
rethink approaches used so far to generate genome-scale models, including WCMs, and to 
integrate with broader communities including software engineers, computer scientists, 
structural biologists, bioinformaticians, and systems and synthetic biologists. 
 We do anticipate that, as diverse communities synergize on WCM-related research, 
different kinds of formalisms might be integrated within genome-scale models. Symbolic 
reasoning (e.g. satisfiability solving, model checking, theorem proving, formal methods, logic 
programming and Boolean networks) provide a range of expressive and intuitive logical 
frameworks that could potentially complement and help glue together sub-models at different 
scales. Such methods are routinely applied to complex systems in the electronics and software 
industries, and have been tentatively applied to biological systems for nearly a decade (128). 
Recent work showed the feasibility of applying logic programming methods to signaling 
pathways (129), metabolic networks (130) and automating a mechanistic philosophy of 
scientific discovery in simulated organisms (131); it should be feasible to integrate such sub-
models within a WCM framework. 
 We believe there is scope to further increase the descriptive and predictive ability of 
WCMs across spatial and temporal scales by integrating the structural biology and the 
molecular modelling communities to carefully consider not only the biochemical, but also the 
physical, molecular and structural components of cells. The development of the so-called 
“physical” WCMs (see (31) and (132) for comprehensive reviews) is an emerging field, with 
the first models describing minimal cellular environments in full atomistic detail (21, 133). 
With the final aim to integrate cellular and physical WCMs within a multiscale framework 
(134), we need approaches which can cope with the limitations of atomistic models of 
biomolecules (mainly in terms of computational resources), possibly exploiting coarse-grained 
(135, 136) or continuum (137) approaches. 
 By collaborating with software engineers, we need to develop tools which can enable, 
and possibly automate, the integration of different data types across scales, model derivation, 
fitting and validation, and visualization and interpretation of results (27). Rule-based models 
might become the new standard to represent each molecular species with the required level of 
granularity and multi-algorithmic sub-models (e.g. flux balance analysis and stochastic 
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dynamical models). Frameworks where intuitive logic is coupled to rule-based models have 
started to be developed recently (52). 
 As we produce ever-increasing amounts of experimental data and increasingly 
sophisticated computational tools to realize detailed and complex representations of actual 
cells, approaches instead focusing on deliberately abstract and parsimonious simulations of 
artificial cellular systems provide a valuable change of perspective. Such “toy models” might 
be a valuable tool to test different algorithms for model derivation and fitting, while offering 
an opportunity to engage with broader research communities and with the public (138). 
 Finally, we believe there is tremendous potential for applying machine learning 
techniques to both WCM derivation and their applications in synthetic biology. Two recent 
works (139, 140) showed that deep neural networks are well placed to reconstruct the 
architecture of living systems (namely, the hierarchical organization of nuclear transcriptional 
factors in the nucleus (139) and of a basic eukaryotic cell (140)) and predict cell states and 
phenotypes. In both cases, the configuration of network layers and thus the biological structure 
were formulated using extensive prior knowledge, ultimately enabling fully “visible” systems, 
where all the internal biological states can be interrogated mechanistically (141). Machine 
learning could be beneficial to systematically process large in vivo and in silico whole-cell 
data-sets, for example by applying Bayesian inference, to integrate data from diverse sources 
and supplement sparse data (142), and to help to automatically classify WCM simulations and 
link phenotypes to genotypes (143). Optimal experimental design techniques might also offer 
a valuable methodology to select the best experimental datasets for both model identification 
and validation (144). 
 
5. Discussion 
We have shown that WCMs are likely to be instrumental to inform design-build-test cycles 
across synthetic biology applications. WCMs can accelerate the realization of “designer” cells 
and organisms tailored to specific functions, reducing experimental iterations and increasing 
the predictive power of computational formalisms used so far. 
In the (re)design of cellular network functionalities, it is therefore important to 
quantitatively analyze and predict, through dedicated modelling strategies, the dynamics of 
interactions between various layers of cellular regulation. Thus, WCMs shall take into account 
how different cellular layers are integrated, and how regulatory feedback among these layers 
occurs in time. These challenges are tackled through integrative computational and 
experimental collaborative efforts aimed, respectively, towards: (i) engineering in vivo network 
designs which, through predictive systems biology, may be able to autonomously oscillate, 
sustaining generation of offspring, and (ii) extraction, visualization and functional exploration 
of regulatory interactions among cellular layers through novel multiscale modeling 
frameworks. 
 As synthetic biology moves toward the (re)engineering of entire genomes and 
multicellular systems, interdisciplinary communities need to collaborate for the development 
of tools that are required to improve the predictive power of WCMs. Although challenges 
remain, it is clear that the adoption of model-based methods has the potential to transform both 
basic research and the current bioproduction development process, leading to marked 
improvements in host performance and product yield on an industrial scale.  
 Ultimately, as the development of human genome-scale kinetic models becomes more 
feasible (27, 145), whole-cell formalisms might become an indispensable tool to study human 
variation, and design bespoke treatments and synthetic cellular screening systems. 
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Figure 1 Integrated design-build-test-learn cycles in synthetic biology encompassing whole-cell model-guided 
approaches, and relative applications. 
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